<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01469507</url>
  </required_header>
  <id_info>
    <org_study_id>V00220 IA 0 01</org_study_id>
    <secondary_id>2011-002295-17</secondary_id>
    <nct_id>NCT01469507</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety Study in Patients Suffering From Knee Osteoarthritis</brief_title>
  <acronym>VESTA</acronym>
  <official_title>Comparative Study of Efficacy and Safety of Three Intra Articular Injections of V0220 Versus Hyalgan® in Patients Suffering From Symptomatic Knee Osteoarthritis. A Multinational Multicentric, Randomised, Double-blind, Parallel-group Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pierre Fabre Medicament</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pierre Fabre Medicament</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to compare a combination of hyaluronic acid and
      chondroitin sulfate (V0220) to Hyalgan® on pain relief in patients with symptomatic knee
      osteoarthritis (OA) over 24 weeks when administered in three weekly injections.

      Chondroitin sulfate is one of the components of cartilage. Studies have shown that
      chondroitin sulphate improves the quality of the hyaluronic acid produced in the joint. The
      benefit of V0220 combination is based on two main physicochemical properties, in line with
      the characteristics of osteoarthritic disease: optimising the rheological behaviour and
      improving the buffering effect on synovial flow (&quot;outflow buffering&quot;).
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain relief assessed on a global pain Visual Analogic Scale</measure>
    <time_frame>change from baseline over 24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional improvement (questionnaire)</measure>
    <time_frame>change from baseline over 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's and investigator's global assessment of the disease status (Visual Analogic Scale )</measure>
    <time_frame>change from baseline over 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's health related quality of life (questionnaire)</measure>
    <time_frame>over 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption of analgesic medication (paracetamol and NSAIDs)(number of days and quantity)</measure>
    <time_frame>over 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medico-economic questionnaire</measure>
    <time_frame>over 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of adverse events</measure>
    <time_frame>over 24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>V0220</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyaluronan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Chondroitin sulfate and sodium hyaluronate</intervention_name>
    <description>3 weekly injections</description>
    <arm_group_label>V0220</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyaluronan</intervention_name>
    <description>3 weekly injections</description>
    <arm_group_label>Hyaluronan</arm_group_label>
    <other_name>Hyalgan®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  presenting with uni or bilateral medial and/or lateral femorotibial osteoarthritis of
             the knee evolving for more than 6 months

          -  patients taking analgesic medications for at least 3 months prior to randomisation and
             dissatisfied with their current therapy

        Exclusion Criteria:

          -  isolated symptomatic femoropatellar osteoarthritis

          -  target knee prothesis

          -  having undergone an articular lavage, or an arthroscopy or any surgery on the target
             knee in the 6 months preceding randomisation,

          -  target knee osteoarthritis with clinical joint effusion at selection and at
             randomization

          -  body mass index (BMI) greater than or equal to 30,

          -  patient having received any corticosteroid treatment by any administration route
             (other than inhalers, ocular, auricular route) in the month preceding randomisation,

          -  patient having received intra-articular steroid injection in the target knee within
             the month preceding randomisation or patient having received intra-articular
             hyaluronic acid in the target knee in the 6 months preceding randomisation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel MAHEU, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>private practice / unaffiliated</affiliation>
  </overall_official>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2011</study_first_submitted>
  <study_first_submitted_qc>November 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2011</study_first_posted>
  <last_update_submitted>February 20, 2013</last_update_submitted>
  <last_update_submitted_qc>February 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

